Volpara Health, a South Korea-based Lunit company and a global leader in software for the early detection of cancer, has announced a significant contract with the US Defense Health Agency (DHA) valued at $7.3 million over five years.

The contract will see Volpara's Patient Hub, an advanced mammography reporting, cancer risk assessment and patient tracking system, deployed across DHA’s military health system. The goal is to modernise breast cancer screening and patient management for military personnel and their families.

The DHA is part of the US Department of Defense and is responsible for healthcare services for approximately 9.6 million active-duty military members, retirees, and their families across the Army, Navy, Air Force, and Marines.

Volpara’s Patient Hub integrates critical aspects of breast health management, including scheduling data collection, risk assessment and mammogram tracking. These features ensure that healthcare providers can deliver personalized, timely care through automated follow-ups, reminders, and patient communications. Patient Hub reduces administrative burdens, streamlines workflow and facilitates adherence to breast health guidelines, all vital to improving early detection and breast cancer outcomes.

This contract marks a significant milestone for Volpara and its ongoing mission to advance breast health through cutting-edge technology.